Philip Bonomi, MD, professor of medical oncology at Rush University Medical Center, discusses how the pool of patients eligible to receive immunotherapy likely should include many individuals who were excluded from early immunotherapy trials.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2022 Healio All Rights Reserved.
Learn. Research. Collaborate.
Begin your journey with Learn Immuno-Oncology.
Test your knowledge and determine where to start.